Protalix BioTherapeutics, Inc. Current Liabilities
Protalix BioTherapeutics, Inc. (PLX) had Current Liabilities of $31.39 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $31.39M.
- 2026-03-31: Liabilities, Current $27.39M.
- 2025-12-31: Liabilities, Current $26.52M.
- 2025-09-30: Liabilities, Current $21.95M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $31.39M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $27.39M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $26.52M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $21.95M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $24.09M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $24.32M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $25.62M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $24.22M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $57.97M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $54.83M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $45.53M 10-K · filed 2025-03-17 | |
| 2023-09-30 | $43.36M 10-Q · filed 2023-11-06 | |
| 2023-06-30 | $23.11M 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $31.52M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $32.43M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $34.30M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.96M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $35.33M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $33.18M 10-K · filed 2023-02-27 | |
| 2021-09-30 | $42.76M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $96.25M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $80.86M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $86.47M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $43.90M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $42.41M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $47.63M 10-Q · filed 2020-06-01 | |
| 2019-12-31 | $40.17M 10-K · filed 2021-03-30 | |
| 2019-09-30 | $33.32M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $25.99M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $27.04M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $25.35M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $24.34M 10-Q · filed 2019-03-18 | $14.55M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $18.49M 10-Q · filed 2019-03-18 | $15.07M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $24.15M 10-Q · filed 2019-03-18 | $21.50M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $22.75M 10-Q · filed 2019-03-18 | |
| 2017-09-30 | $26.59M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $19.12M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $20.29M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $66.21M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $10.33M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $11.46M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $9.28M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $11.23M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $22.85M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $25.52M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $26.55M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $64.35M 10-K · filed 2016-03-08 | $26.21M 10-K · filed 2015-03-12 |
| 2014-09-30 | $24.38M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $27.18M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $26.78M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $26.70M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $25.23M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $26.63M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $24.41M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $25.75M 10-K · filed 2014-03-13 | |
| 2012-09-30 | $20.43M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $21.33M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $17.72M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $18.69M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $18.31M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $20.28M 10-Q · filed 2011-08-08 | |
| 2010-12-31 | $18.90M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |